TrialJAMA ophthalmology2020

Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The AVENUE Phase 2 Randomized Clinical Trial.

Jayashree Sahni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.